期刊文献+

超声引导下A型肉毒毒素注射治疗良性前列腺增生的疗效观察

原文传递
导出
摘要 良性前列腺增生(benign prostatic hyperplasia,BPH)是中老年男性常见疾病。A型肉毒毒素(botulinum toxin type A,BTX—A)注射治疗BPH是近年来发展起来的治疗方法,目前国内外研究对BTX—A治疗BPH疗效报道不一。笔者采用超声引导下BTX—A注射治疗BPH患者,治疗效果较好,操作方便,患者易耐受。现报道如下。
出处 《中华物理医学与康复杂志》 CAS CSCD 北大核心 2015年第7期486-487,共2页 Chinese Journal of Physical Medicine and Rehabilitation
  • 相关文献

参考文献11

  • 1AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1 : Diagnosis and treat- ment recommendations[ J]. J Urol,2003,170(2 Pt 1 ) :530-547. 被引量:1
  • 2那彦群主编..中国泌尿外科疾病诊断治疗指南[M].北京:人民卫生出版社,2006:190.
  • 3张鹏,武治津,杨勇,张小东.多沙唑嗪控释片短期服用对前列腺增生症患者下尿路症状及IPSS评分的影响[J].中华医学杂志,2010,90(40):2826-2829. 被引量:8
  • 4Wasserman NF. Benign prostatic hyperplasia: a review and ultrasound classification [ J]. Radiol Clin North Am, 2006,44(5) :689-710. 被引量:1
  • 5Lu-Yao GL, Barry M J, Chang CH, et al. Transurethral resection of the prostate among Medicare beneficiaries in the United States: time trends and outcomes[J]. Urology, 1994, 44(5) : 692-699. 被引量:1
  • 6Welch M J, Purkiss JR, Foster KA. Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neutrotoxins [ J ]. Toxi- con, 2000,38(2) :245-258. 被引量:1
  • 7Chuang YC,Chancellor MB. The application of botulinum toxin in the prostate [ J ]. J Urol,2006,176 ( 6 ) :2375-2382. 被引量:1
  • 8Smith CP,Chancellor MB. Emerging role of botulinum toxin in the ma- nagement of voiding dysfunction [ J ]. J Urol, 2004,171 ( 6 ) : 2128- 2137. 被引量:1
  • 9Wyndaele JJ, Van Dromme SA. Muscular weakness as side effects of botulinum toxin injection for neurogenic detrusour overactivity [ J ]. Spinal Cord ,2002, 40( 11 ) :599-600. 被引量:1
  • 10丁旭东,陈华先,汪伟,王汉,黄瓅.A型肉毒毒素注射联合踝足矫形器治疗对脑卒中偏瘫患者下肢痉挛的影响[J].中华物理医学与康复杂志,2014,36(5):349-352. 被引量:12

二级参考文献30

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33055
  • 2周晓峰.多沙唑嗪有效改善BPH患者排尿症状[J].中国男科学杂志,2006,20(12):2-2. 被引量:1
  • 3邵宇权,胡兴越.A型肉毒毒素局部注射治疗肢体肌张力障碍及痉挛的疗效观察[J].中华物理医学与康复杂志,2007,29(7):479-480. 被引量:10
  • 4Nickel JC,Sander S,Moon TD.A meta-analysis of the vascularrelated safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasia.Int J Clin Pract,2008,62:1547-1559. 被引量:1
  • 5Steers WD,Kirby RS.Clinical ease of using doxazosin in BPH patients with and without hypertension.Prostate Cancer Prostatic Dis,2005,8:152-157. 被引量:1
  • 6MacDonald R,Wilt TJ,Howe RW.Doxazosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction:a systematic review of efficacy and adverse effects.BJU Int,2004,94:1263-1270. 被引量:1
  • 7Barry MJ,Fowler FJ Jr,O' Leary MP,et al.The American Urological Association symptom index for benign prostatic hyperplasia.The Measurement Committee of the American Urological Association.J Urol,1992,148:1549-1557; 1564. 被引量:1
  • 8Eckhardt MD,van Venrooij GE,Boon TA.Symptoms and quality of life versus age,prostate volume,and urodynamic parameters in 565 strictly selected men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.Urology,2001,57:695-700. 被引量:1
  • 9Glasser DB,Carson C 3rd,Kang JH,et al.Prevalence of storage and voiding symptoms among men aged 40 years and older in a US population-based study:results from the male attitudes regarding sexual health study.Int J Clin Pract,2007,61:1294-1300. 被引量:1
  • 10McConnell JD,Roehrborn CG,Bautista OM,et al.The long-term effect of doxazosin,finasteride,and combination therapy on the clinical progression of benign prostatic hyperplasia.N Engl J Med,2003,349:2387 -2398. 被引量:1

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部